Mergers & Acquisitions - Respiratory and Pulmonary, Pharmaceutical

Filter

Popular Filters

1 to 25 of 28 results

Ario Pharma acquires PharmEste’s TRPA1 research assets

11-09-2014

Cambridge, UK-based biopharma company Ario Pharma says it has acquired the TRPA1 antagonist research…

Ario PharmaInflammatory diseasesMergers & AcquisitionsPharmaceuticalPharmEsteRespiratory and Pulmonary

Roche makes another acquisition, paying $8.3 billion for InterMune

Roche makes another acquisition, paying $8.3 billion for InterMune

25-08-2014

Announcing its fourth acquisition this year, Swiss pharma major Roche said on Sunday that it has entered…

EsbrietInterMuneMergers & AcquisitionsPharmaceuticalRespiratory and PulmonaryRoche

AstraZeneca to acquire Almirall’s respiratory franchise, for up to $2.1 billion

AstraZeneca to acquire Almirall’s respiratory franchise, for up to $2.1 billion

30-07-2014

Anglo-Swedish pharma major AstraZeneca has entered an agreement to gain rights to the respiratory franchise…

AlmirallAstraZenecaEkliraMergers & AcquisitionsPharmaceuticalRespiratory and Pulmonary

Stallergenes expands in Latin American with acquisition of Alergo Pharma

Stallergenes expands in Latin American with acquisition of Alergo Pharma

22-07-2014

French allergen specialist Stallergenes said this morning that it has acquired full ownership of Alergo…

Alergo PharmaAllergologyArgentinaImmunologyMedicineMergers & AcquisitionsPharmaceuticalRespiratory and PulmonaryStallergenes

AstraZeneca stresses confidence in independence, highlighting strong R&D pipeline

15-05-2014

Anglo-Swedish pharma major AstraZeneca, the subject of the controversial takeover attempt by Pfizer,…

AstraZenecaCardio-vascularMergers & AcquisitionsMetabolicsOncologyPharmaceuticalResearchRespiratory and Pulmonary

Bayer shells out $14.2 billion for Merck & Co OTC business; firms to collaborate on sGC modulators

Bayer shells out $14.2 billion for Merck & Co OTC business; firms to collaborate on sGC modulators

06-05-2014

Confirming strong rumors over the past week or so, German pharma major Bayer confirmed it has agreed…

AdempasBayerLicensingMerck & CoMergers & AcquisitionsPharmaceuticalResearchRespiratory and Pulmonaryvericiguat

OPKO to buy Israel’s Inspiro, gaining rights to new drug delivery technology

18-04-2014

US biopharma company OPKO Health has entered into a definitive agreement to acquire Inspiro Medical an…

Inspiro MedicalMergers & AcquisitionsOPKO HealthPharmaceuticalRespiratory and Pulmonary

Vectura to buy Germany’s Activaero for 130 million euros

Vectura to buy Germany’s Activaero for 130 million euros

14-03-2014

UK developer of inhaled therapies Vectura says it is acquiring privately-held German company Activaero…

ActivaeroFinancialMergers & AcquisitionsPharmaceuticalRespiratory and PulmonaryVectura

Mast Therapeutics to acquire Aires Pharma

10-02-2014

USA-based Mast Therapeutics has entered into a definitive agreement to acquire privately-held clinical-stage…

AIR001Aires PharmaceuticalsMast TherapeuticsMergers & AcquisitionsPharmaceuticalRespiratory and Pulmonary

Ikaria sells commercial business to Madison Dearborn for $1.6 billion

03-01-2014

US critical care company Ikaria says that its investor group and employee shareholders have reached a…

IkariaInomaxMergers & AcquisitionsPharmaceuticalRespiratory and Pulmonary

Meda acquires US respiratory company

02-09-2013

Swedish drugmaker Meda (STO:MEDAA) has signed an agreement to acquire the US development company Acton…

Acton PharmaceuticalsAerospan HFAFlunisolideMedaMergers & AcquisitionsPharmaceuticalRespiratory and Pulmonary

Teva to expand respiratory business with up to $165 million acquisition of MicroDose Therapeutx

18-06-2013

Israel-based Teva Pharmaceutical Industries (NYSE: TEVA) has entered into a definitive agreement to acquire…

Mergers & AcquisitionsMicroDose TherapeutxPharmaceuticalRespiratory and PulmonaryTeva Pharmaceutical Industries

Zambon to acquire UK respiratory specialist Profile Pharma

10-06-2013

Family-owned Italian drugmaker Zambon has taken a significant step to grow in the respiratory therapy…

Mergers & AcquisitionsPharmaceuticalProfile PharmaPromixinRare diseasesRespiratory and PulmonaryZambon

AstraZeneca to pay up to $1.15 billion to acquire Pearl Therapeutics

10-06-2013

In a further "strategic" bolt-on acquisition for Anglo-Swedish drug major AstraZeneca (LSE: AZN) in less…

AstraZenecaMergers & AcquisitionsPearl TherapeuticsPharmaceuticalPT003Respiratory and Pulmonary

Grifols gains global rights to Aradigm's Pulmaquin

23-05-2013

Spanish drugmaker Grifols (GRLS: MC) has signed an exclusive, worldwide license for USA-based Aradigm's…

Antibiotics and Infectious diseasesAradigmCiprofloxacinGrifolsLicensingMergers & AcquisitionsPharmaceuticalPulmaquinRespiratory and Pulmonary

Vectura sets up JV, Kinnovata, for new respiratory business in China

13-05-2013

UK-based developer of inhaled therapies Vectura (LSE: VEC) saw its shares rise 4.8% to 96.93 pence in…

Asia-PacificMergers & AcquisitionsPharmaceuticalProductionRespiratory and PulmonaryTianjin KingYorkTianjin Kinnovata PharmaVecturaZendex Bio Strategy

Theravance to split into two, halting speculation of a full takeover by GSK

29-04-2013

US drug developer Theravance (Nasdaq: THRX) has announced its intention to create two independent publicly…

Anoro ElliptaBiotechnologyBreo ElliptaGlaxoSmithKlineManagementMergers & AcquisitionsPharmaceuticalRespiratory and PulmonaryRoyalty Management CoTheravanceTheravance Biopharma

Ares Life Sciences to make second 2013 acquisition, the USA's Antigen Laboratories

15-04-2013

Ares Life Sciences has signed a definitive agreement to acquire 100% of the share capital of privately-held…

Antigen LaboratoriesAres Life SciencesMergers & AcquisitionsPharmaceuticalPlanet BiopharmaceuticalsRespiratory and Pulmonary

Ares Life Sciences to acquire Albion Medical and its GREER Laboratories unit

08-03-2013

Ares Life Sciences says it has signed a definitive agreement to acquire 100% of the share capital of…

Albion MedicalAres Life SciencesGREER LaboratoriesImmunologicalsMergers & AcquisitionsOralairPharmaceuticalRespiratory and PulmonaryStallergenes

Briefs: Sanofi to up stake in Regeneron; Bayer files for riociguat approval

12-02-2013

US biotech Regeneron Pharmaceuticals (Nasdaq: REGN) saw its shares rise 4.8% to $173.84 in early trading…

BayerBiotechnologyEuropeFinancialMergers & AcquisitionsNorth AmericaPharmaceuticalRegeneronRegulationRespiratory and PulmonaryriociguatSanofi

News briefs from Sanofi, Bayer, GlaxoSmithKline and Novartis

21-12-2012

French drug major Sanofi (Euronext: SAN) has entered into a binding agreement to acquire the animal health…

BayerDosch PharmaceuticalsExjadeFlonaseGlaxoSmithKlineLegalMergers & AcquisitionsMerialNovartisOncologyPharmaceuticalregorafenibRegulationRespiratory and PulmonarySanofi

Fresenius Kabi sells respiratory homecare business in France

17-12-2012

Germany-based Fresenius Kabi, a provider of infusion therapy and clinical nutrition. has signed an agreement…

BiotechnologyFresenius BiotechFresenius KabiMergers & AcquisitionsPharmaceuticalRespiratory and Pulmonary

Sunovion to acquire Elevation Pharma for up to $430 million

03-09-2012

Sunovion Pharmaceuticals, a US subsidiary of Japan's Dainippon Sumitomo Pharma (TYO: 4506) last week…

Dainippon Sumitomo PharmaElevation PharmaceuticalsEP-101Mergers & AcquisitionsPharmaceuticalRespiratory and PulmonarySunovion

1 to 25 of 28 results

Back to top